1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine

Toxicology and Applied Pharmacology

Volumn 218, Issue 1, 2007, Pages 37-44

  Kutuzova, Galina D ^a   DeLuca, Hector F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cytochrome P450 (CYP); Microarrays; Phase I and phase II biotransformation; VDR; Vitamin D and intestine

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL RECEPTOR; CYTOCHROME P450; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BIOTRANSFORMATION; BREAST CANCER; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; DETOXIFICATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNE SYSTEM; INTESTINE; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PROSTATE CANCER; RAT;

ANIMALS; ANTIOXIDANTS; BIOTRANSFORMATION; CALCITRIOL; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; DUODENUM; EPOXIDE HYDROLASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE (DECYCLIZING); MALE; METABOLIC DETOXICATION, DRUG; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID HYDROXYLASES; TIME FACTORS; TRANSFERASES; VITAMIN D DEFICIENCY; VITAMINS;

MAMMALIA; RATTUS;

EID: 33845864150     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.10.005     Document Type: Article

References (50)

1. Adachi R., Shulman A.I., Yamamoto K., Shimomura I., Yamada S., Mangelsdorf D.J., and Makishima M. Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol. Endocrinol. 18 (2004) 43-52
2. Anakk S., Ku C.Y., Vore M., and Strobel H.W. Insights into gender bias: rat cytochrome P450 3A9. J. Pharmacol. Exp. Ther. 305 (2003) 703-709
3. Backlund M., Johansson I., Mkrtchian S., and Ingelman-Sundberg M. Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. J. Biol. Chem. 272 (1997) 31755-31763
4. Bacon E.J., Brown K., Wolf C.R., Ure J., Henderson C.J., and Smith A.G. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5275-5280
5. Baker M.E. Bacterial 3alpha-hydroxysteroid dehydrogenase is homologous to a fusion of bacterial ribosomal L10 and L7/12 genes. J. Steroid. Biochem. Mol. Biol. 59 (1996) 365-366
6. Baker R., McDonnel D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., and O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 3294-3298
7. Barbier O., Villeneuve L., Bocher V., Fontaine C., Torra I.P., Duhem C., Kosykh V., Fruchart J.C., Guillemette C., and Staels B. The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J. Biol. Chem. 278 (2003) 13975-13983
8. Beaudet M.J., Desrochers M., Lachaud A.A., and Anderson A. The CYP2B2 phenobarbital response unit contains binding sites for hepatocyte nuclear factor 4, PBX-PREP1, the thyroid hormone receptor beta and the liver X receptor. Biochem. J. 388 (2005) 407-418
9. 3 receptor. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 9499-9502
10. 3 receptor to positive and negative vitamin D response elements. Arch. Biochem. Biophys. 334 (1996) 223-234
11. De Launoit Y., and Adamski J. Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J. Mol. Endocrinol. 22 (1999) 227-240
12. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80 (2004) 1689S-1696S (Suppl.)
13. Dhakshinamoorthy S., and Jaiswal A.K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20 (2001) 3906-3917
14. Doherty M.M., and Charman W.N. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?. Clin. Pharmacokinet. 41 (2002) 235-253
15. Dusso A.S., Thadhani R., and Slatopolsky E. Vitamin D receptor and analogs. Semin. Nephrol. 24 (2004) 10-16
16. Ekins S., and Wrighton S.A. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 31 (1999) 719-754
17. Fujita K., Nagata K., Watanabe E., Shimada M., and Yamazoe Y. Bacterial expression and functional characterization of a rat thyroid hormone sulfotransferase, ST1B1. Jpn. J. Pharmacol. 79 (1999) 467-475
18. 3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J. Neurochem. 73 (1999) 859-866
19. Halloran B.P., and DeLuca H.F. Calcium transport in small intestine during early development: role of vitamin D. Arch. Biochem. Biophys. 208 (1981) 477-486
20. Honkakoski P., Zelko I., Sueyoshi T., and Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18 (1998) 5652-5658
21. Jones G., Strugnell S.A., and DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 78 (1998) 1193-1231
22. Kalsotra A., Cui X., Anakk S., Hinojos C.A., Doris P.A., and Strobel H.W. Renal localization, expression, and developmental regulation of P450 4F cytochromes in three substrains of spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 338 (2005) 423-431
23. Kaminsky L.S., and Zhang Q.Y. The small intestine as a xenobiotic-metabolizing organ. Drug Metab. Dispos. 31 (2003) 1520-1525
24. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., and Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19 (1999) 6318-6322
25. Kiyokage E., Toida K., Suzuki-Yamamoto T., and Ishimura K. Localization of 5alpha-reductase in the rat main olfactory bulb. J. Comp. Neurol. 493 (2005) 381-395
26. Kutuzova G.D., and DeLuca H.F. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties. Arch. Biochem. Biophys. 432 (2004) 152-166
27. Lelivelt M.J., and Culbertson M.R. Yeast Upf proteins required for RNA surveillance affect global expression of the yeast transcriptome. Mol. Cell. Biol. 19 (1999) 6710-6719
28. Lockhart D.J., and Winzeler E.A. Genomics, gene expression and DNA arrays. Nature 405 (2000) 827-836
29. Luo G., Guenthner T., Gan L.S., and Humphreys W.G. CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr. Drug Metab. 5 (2004) 483-505
30. McCarver D.G., and Hines R.N. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J. Pharmacol. Exp. Ther. 300 (2002) 361-366
31. 3 receptor regulate osteocalcin gene expression. Mol. Endocrinol. 3 (1989) 635-644
32. Mooijaart S.P., Brandt B.W., Baldal E.A., Pijpe J., Kuningas M., Beekman M., Zwaan B.J., Slagboom P.E., Westendorp R.G., and van Heemst D. C. elegans DAF-12, Nuclear hormone receptors and human longevity and disease at old age. Ageing Res. Rev. 4 (2005) 351-371
33. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26 (2005) 662-687
34. Nguyen T., Sherratt P.J., and Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 233-260
35. Obach R.S., Zhang Q.Y., Dunbar D., and Kaminsky L.S. Metabolic characterization of the major human small intestinal cytochrome P450s. Drug Metab. Dispos. 29 (2001) 347-352
36. Ohyama Y., and Yamasaki T. Eight cytochrome P450s catalyze vitamin D metabolism. Front. Biosci. 9 (2004) 3007-3018
37. Rendic S., and Di Carlo F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab. Rev. 29 (1997) 413-580
38. Rushmore T.H., and Kong A.N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 3 (2002) 481-490
39. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., and Ishikawa T. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 779-782
40. Smirlis D., Muangmoonchai R., Edwards M., Phillips I.R., and Shephard E.A. Orphan receptor promiscuity in the induction of cytochromes P450 by xenobiotics. J. Biol. Chem. 276 (2001) 12822-12826
41. Suda T., DeLuca H.F., and Tanaka Y. Biological activity of 25-hydroxyergocalciferol in rats. J. Nutr. 100 (1970) 1049-1052
42. Takemoto K., Yamazaki H., Tanaka Y., Nakajima M., and Yokoi T. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica 33 (2003) 43-55
43. Thompson C.M., Capdevila J.H., and Strobel H.W. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J. Pharmacol. Exp. Ther. 294 (2000) 1120-1130
44. Thompson P.D., Jurutka P.W., Whitfield G.K., Myskowski S.M., Eichhorst K.R., Dominguez C.E., Haussler C.A., and Haussler M.R. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem. Biophys. Res. Commun. 299 (2002) 730-738
45. 3. Mol. Pharmacol. 60 (2001) 1399-1406
46. Townsend D.M., Findlay V.L., and Tew K.D. Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol. 401 (2005) 287-307
47. Tsuruo Y. Topography and function of androgen-metabolizing enzymes in the central nervous system. Anat. Sci. Int. 80 (2005) 1-11
48. Whitlock J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 103-125
49. Xue L., Zgoda V.G., Arison B., and Correia M.A. Structure-function relationships of rat liver CYP3A9 to its human liver ortholog: site-directed active site mutagenesis to a progesterone dihydroxylase. Arch. Biochem. Biophys. 409 (2003) 113-126
50. Zhou J., Zhang J., and Xie W. Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr. Drug Metab. 6 (2005) 289-298